KMT2A and cancer: Beyond the well‐characterized somatic dysregulation resulting from KMT2A‐rearranged pediatric leukemia, recent studies have shown KMT2A‐D variants are indeed among the most frequent genomic alterations in a variety of human malignant neoplasms with associations to common blood and solid tumor cancers.2, 3